ReviewPharmaceuticals (Basel, Switzerland)2026
Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence.
Amro Abu Suleiman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.